Form 483

Alliance Medical Products, Inc. Form 483, 2009-05-05

FDA issued a Form 483 to Alliance Medical Products, Inc. on 2009-05-05 with 11 public-safe observations.

483· Form 483 issued11 observations

Alliance Medical Products, Inc. · Irvine, United States · Issued May 5, 2009

Overview

  • 11 public-safe observations are available for this inspection.
  • 11 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

5 May 2009
21 CFR 211.22(c)

Approve or reject procedures or specs

Cited by Caryn M Mcnab

5 May 2009
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Caryn M Mcnab

5 May 2009
21 CFR 211.63

Equipment Design, Size and Location

Cited by Caryn M Mcnab

5 May 2009
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Caryn M Mcnab

5 May 2009
21 CFR 211.110(a)

Control procedures fail to include the following

Cited by Caryn M Mcnab

Inspected site

AMAlliance Medical Products, Inc.Irvine, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.180(b)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 11 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere